Skip to main content

American Vanguard Reports First Quarter 2021 Results

American Vanguard Corporation (NYSE: AVD) today announced financial results for the first quarter ended March 31, 2021.

Fiscal 2021 First Quarter Financial Highlights versus Fiscal 2020 First Quarter:

  • Net sales were $116 million in 2021, compared to $96 million in 2020.
  • Net income was $3.07 million in 2021, compared to $0.52 million in 2020.
  • Earnings per diluted share of $0.10 in 2021, compared to $0.02 in 2020.
  • EBITDA1of $12.1 million in 2021, compared to $7.6 million in 2020.

Eric Wintemute, Chairman and CEO of American Vanguard stated: “We are pleased to report a much-improved start to 2021 both at the top and bottom lines, as compared to the prior year. Domestically, after several years of relatively stagnant crop prices, we are beginning to see higher commodity prices, which, in turn, has helped spur demand for both our soybean products and our corn herbicide portfolio. In non-crop uses, we experienced steady demand for mosquito control products, a recovery in the horticulture segment and higher royalties from our essential oil products for consumer use. Internationally, we enjoyed improved performance in Mexico and Brazil, while continuing to expand globally with the additions of Agrinos biological products and the integration of AgNova in Australia. Gross profit margins were just below those of the comparable quarter in 2020, while net income for the quarter was 6 times that of the prior year period.”

He continued: “During the quarter, we kept a focus on balance sheet integrity and controlled inventory levels. We also exercised discipline with respect to operating expense (which declined as a percent of net sales) and debt management within the usual seasonal cycle for our business. Further, we produced profitable results while self-funding strategic growth initiatives, including our SIMPAS prescription application system with the Ultimus tracing/verification platform, which we are positioning as a comprehensive solution for the carbon credit market.”

Mr. Wintemute concluded: “Over the course of 2021, we expect a low double-digit increase in net sales with stronger growth in net income. We look forward to giving you additional detail on market conditions, profitability, working capital considerations and our innovation initiatives during our upcoming earnings call.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, COO and David T. Johnson, CFO, will conduct a conference call focusing on operating performance and financial results at 4:30 pm ET / 1:30 pm PT on Thursday, May 6, 2021. Interested parties may participate in the call by dialing 888-506-0062 or 973-528-0011 and enter code 481120 - please call in 10 minutes before the conference is scheduled to begin and ask for the American Vanguard conference.

The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 

ASSETS

 

 

March 31,

2021

 

 

December 31,

2020

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

13,765

 

 

$

15,923

 

Receivables:

 

 

 

 

 

 

 

 

Trade, net of allowance for doubtful accounts of $3,979 and $3,297, respectively

 

 

156,010

 

 

 

130,029

 

Other

 

 

10,247

 

 

 

8,444

 

Total receivables, net

 

 

166,257

 

 

 

138,473

 

Inventories

 

 

172,234

 

 

 

163,784

 

Prepaid expenses

 

 

11,221

 

 

 

10,499

 

Income taxes receivable

 

 

2,409

 

 

 

3,046

 

Total current assets

 

 

365,886

 

 

 

331,725

 

Property, plant and equipment, net

 

 

65,945

 

 

 

65,382

 

Operating lease right-of-use assets

 

 

11,207

 

 

 

12,198

 

Intangible assets, net of applicable amortization

 

 

193,776

 

 

 

197,514

 

Goodwill

 

 

50,505

 

 

 

52,108

 

Other assets

 

 

18,492

 

 

 

18,602

 

Deferred income tax assets, net

 

 

4,213

 

 

 

2,764

 

Total assets

 

$

710,024

 

 

$

680,293

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current liabilities:

 

 

 

 

 

 

 

 

Current installments of other liabilities

 

$

909

 

 

$

2,647

 

Accounts payable

 

 

60,946

 

 

 

59,253

 

Deferred revenue

 

 

32,316

 

 

 

43,611

 

Accrued program costs

 

 

53,196

 

 

 

45,441

 

Accrued expenses and other payables

 

 

15,865

 

 

 

16,184

 

Operating lease liabilities, current

 

 

3,664

 

 

 

4,188

 

Total current liabilities

 

 

166,896

 

 

 

171,324

 

Long-term debt, net

 

 

143,423

 

 

 

107,442

 

Operating lease liabilities, long term

 

 

7,692

 

 

 

8,177

 

Other liabilities, net of current installments

 

 

8,453

 

 

 

9,054

 

Deferred income tax liabilities, net

 

 

23,514

 

 

 

23,560

 

Total liabilities

 

 

349,978

 

 

 

319,557

 

Commitments and contingent liabilities

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

 

 

 

 

 

 

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 33,874,322 shares at March 31, 2021 and 33,922,433 shares at December 31, 2020

 

 

3,389

 

 

 

3,394

 

Additional paid-in capital

 

 

95,985

 

 

 

96,642

 

Accumulated other comprehensive loss

 

 

(11,825

)

 

 

(9,322

)

Retained earnings

 

 

290,657

 

 

 

288,182

 

Less treasury stock at cost, 3,061,040 shares

 

 

(18,160

)

 

 

(18,160

)

Total stockholders’ equity

 

 

360,046

 

 

 

360,736

 

Total liabilities and stockholders' equity

 

$

710,024

 

 

$

680,293

 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

For the three months

ended March 31

 

 

 

2021

 

 

2020

 

Net sales

 

$

116,155

 

 

$

95,962

 

Cost of sales

 

 

(71,024

)

 

 

(57,581

)

Gross profit

 

 

45,131

 

 

 

38,381

 

Operating expenses

 

 

(41,444

)

 

 

(36,545

)

Adjustment to bargain purchase gain on business acquisition

 

 

(33

)

 

 

 

Operating income

 

 

3,654

 

 

 

1,836

 

Change in fair value of an equity investment

 

 

1,066

 

 

 

 

Other income

 

 

672

 

 

 

 

Interest expense, net

 

 

(946

)

 

 

(1,508

)

Income before provision for income taxes (benefit) and loss on equity method investment

 

 

4,446

 

 

 

328

 

Income tax (expense) benefit

 

 

(1,362

)

 

 

205

 

Income before loss from equity method investment

 

 

3,084

 

 

 

533

 

Loss from equity method investment

 

 

(13

)

 

 

(13

)

Net income

 

$

3,071

 

 

$

520

 

Earnings per common share—basic

 

$

0.10

 

 

$

0.02

 

Earnings per common share—assuming dilution

 

$

0.10

 

 

$

0.02

 

Weighted average shares outstanding—basic

 

 

29,737

 

 

 

29,288

 

Weighted average shares outstanding—assuming dilution

 

 

30,523

 

 

 

29,948

 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

(In thousands)

(Unaudited)

 

 

 

For the three Months Ended

March 31

 

 

 

2021

 

 

2020

 

 

Change

 

 

% Change

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. crop

 

$

54,755

 

 

$

50,362

 

 

$

4,393

 

 

 

9

%

U.S. non-crop

 

 

17,453

 

 

 

10,993

 

 

 

6,460

 

 

 

59

%

Total U.S.

 

 

72,208

 

 

 

61,355

 

 

 

10,853

 

 

 

18

%

International

 

 

43,947

 

 

 

34,607

 

 

 

9,340

 

 

 

27

%

Total net sales:

 

$

116,155

 

 

$

95,962

 

 

$

20,193

 

 

 

21

%

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. crop

 

$

21,271

 

 

$

24,245

 

 

$

(2,974

)

 

 

-12

%

U.S. non-crop

 

 

9,383

 

 

 

4,719

 

 

 

4,664

 

 

 

99

%

Total U.S.

 

 

30,654

 

 

 

28,964

 

 

 

1,690

 

 

 

6

%

International

 

 

14,477

 

 

 

9,417

 

 

 

5,060

 

 

 

54

%

Total gross profit:

 

$

45,131

 

 

$

38,381

 

 

$

6,750

 

 

 

18

%

Gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. crop

 

 

39

%

 

 

48

%

 

 

 

 

 

 

 

 

U.S. non-crop

 

 

54

%

 

 

43

%

 

 

 

 

 

 

 

 

Total U.S.

 

 

42

%

 

 

47

%

 

 

 

 

 

 

 

 

International

 

 

33

%

 

 

27

%

 

 

 

 

 

 

 

 

Gross margin:

 

 

39

%

 

 

40

%

 

 

 

 

 

 

 

 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

For the three months

ended March 31

 

 

 

2021

 

 

2020

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

3,071

 

 

$

520

 

Adjustments to reconcile net income to net cash used in operating

activities:

 

 

 

 

 

 

 

 

Depreciation and amortization of fixed and intangible assets

 

 

5,403

 

 

 

4,762

 

Amortization of other long-term assets

 

 

1,200

 

 

 

967

 

Accretion of discounted liabilities

 

 

18

 

 

 

4

 

Amortization of deferred loan fees

 

 

81

 

 

 

59

 

Provision for bad debts

 

 

682

 

 

 

359

 

Loan principal and interest forgiveness

 

 

(672

)

 

 

 

Stock-based compensation

 

 

1,792

 

 

 

1,357

 

Decrease in deferred income taxes

 

 

(269

)

 

 

(910

)

Change in fair value of an equity investment

 

 

(1,066

)

 

 

 

Loss from equity method investment

 

 

13

 

 

 

13

 

Adjustment to bargain purchase gain on business acquisition

 

 

33

 

 

 

 

Changes in assets and liabilities associated with operations:

 

 

 

 

 

 

 

 

Increase in net receivables

 

 

(30,422

)

 

 

(6,578

)

Increase in inventories

 

 

(9,615

)

 

 

(16,446

)

Increase in prepaid expenses and other assets

 

 

(1,052

)

 

 

(776

)

(Increase) decrease in income tax receivable/payable, net

 

 

638

 

 

 

(597

)

Decrease in net operating lease liability

 

 

(18

)

 

 

 

Increase in accounts payable

 

 

2,293

 

 

 

1,617

 

Decrease in deferred revenue

 

 

(11,293

)

 

 

(2,342

)

Increase in accrued program costs

 

 

7,770

 

 

 

6,016

 

Decrease in other payables and accrued expenses

 

 

(1,187

)

 

 

(2,094

)

Net cash used in operating activities

 

 

(32,600

)

 

 

(14,069

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(2,904

)

 

 

(2,980

)

Intangible assets

 

 

(41

)

 

 

 

Net cash used in investing activities

 

 

(2,945

)

 

 

(2,980

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net borrowings under line of credit agreement

 

 

35,900

 

 

 

19,400

 

Net payments from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholdings)

 

 

(2,454

)

 

 

(2,177

)

Payment of cash dividends

 

 

(593

)

 

 

(582

)

Net cash provided by financing activities

 

 

32,853

 

 

 

16,641

 

Net decrease in cash and cash equivalents

 

 

(2,692

)

 

 

(408

)

Effect of exchange rate changes on cash and cash equivalents

 

 

534

 

 

 

(629

)

Cash and cash equivalents at beginning of period

 

 

15,923

 

 

 

6,581

 

Cash and cash equivalents at end of period

 

$

13,765

 

 

$

5,544

 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA

For the three months March 31, 2021 and 2020

(Unaudited)

 

 

 

March 31, 2021

 

 

March 31, 2020

 

Net income, as reported

 

$

3,071

 

 

$

520

 

Provision for income taxes

 

 

1,362

 

 

 

(205

)

Interest expense, net

 

 

946

 

 

 

1,508

 

Depreciation and amortization

 

 

6,684

 

 

 

5,788

 

EBITDA2

 

$

12,063

 

 

$

7,611

 


1 Earnings before interest, taxes, depreciation, and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently.

2 Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.